pg twice a day inhaled with (n = 10) or without (n = 14) a Volumatic spacing device were switched to a budesonide dry powder inhaler, 600 pg to be taken twice a day without mouth rinsing. In study 2 10 patients took budesonide 800 pg twice a day with and without mouth rinsing and without swallowing the rinsing water. In study 3 For the 10 patients taking beclomethasone Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroidsfrom a metered dose inhaler and dry powder inhaler893 dipropionate with a spacer cortisol concentrations were significantly higher than after they had changed to budesonide without mouth rinsing (table 2) . These patients also had higher 24 hour urinary cortisol excretion when taking beclomethasone than when taking budesonide (p < 0 001 If the swallowed drug is important it is surprising that no difference in mean serum cortisol values was seen between patients taking beclomethasone dipropionate with a spacer and those taking it without a spacer in study 1. This may reflect differences in serum cortisol between patients in the two groups due to other factors.
Mouth rinsing has usually been recommended to avoid oropharyngeal candidiasis, rather than as a protection against systemic side effects. If the swallowed part of the inhaled dose is important in determining systemic absorption, it is important to give patients instructions on what to do with the rinsing water. In study 2 patients were told clearly to rinse or not to rinse their mouth after inhalation and to spit out the rinsing water after rinsing. Plasma cortisol concentrations were significantly higher when the patients spat out the rinsing water.
We further tested the hypothesis that the swallowed dose is important in study 3 by comparing the best alternatives in 17 patientsthat is, beclomethasone dipropionate via the Volumatic and budesonide via the Turbuhaler with mouth rinsing and spitting out the rinse water. There was no significant difference in the concentration of plasma or urinary cortisol when the patients used beclomethasone dipropionate 500 Mg twice daily with a spacing device and mouth rinsing and budesonide 800
Mg twice daily with mouth rinsing. The dose of budesonide was 60% higher than the dose of beclomethasone dipropionate. The two drugs had a similar effect on the cortisol concentrations, however, presumably because of the more rapid metabolism of budesonide. These results are in agreement with those of Lofdahl et al," who showed that the dose of budesonide could be 70% greater than the dose of beclomethasone dipropionate with the same plasma cortisol concentrations.
The results of these studies indicate that the swallowed part of an inhaled dose of glucocorticosteroids is important. This is presumaly because it contributes to the total bioavailability of the drug. To decrease the effect of inhaled corticosteroids on serum and urinary cortisol, and to avoid oropharyngeal candidiasis, patients using an inhaled corticosteroid without a spacing device should be advised to rinse their mouth after inhalation and to spit out the rinsing water. The higher the daily dose of the corticosteroid the more important this advice is.
We gratefully acknowledge the assistance of Mrs Ann-Britt Lofroos, clinical research assistant, in monitoring the studies and of Dr Tore Persson in giving statistical guidance. 
